10-K 0000004127-25-000085 (2025-11-07) vs 10-K 0000004127-24-000131 (2024-11-15)
| Section | Compared text | Words now | Changed |
| Risk Factors | Item 1A | 16,859 |
29.3% |
| MD&A | Item 7 | 3,778 |
31.0% |
| Legal Proceedings | Item 3, via Note 11 – COMMITMENTS AND CONTINGENCIES | 673 |
20.3% |
| Accounting Policies | Item 8, Note 2 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3,838 |
14.8% |
The redline: what was cut and what was added
In each section, the paragraph that changed most, marked against last year's 10-K:
cut words struck through, new words highlighted and underlined.
Risk Factors 334 words changed in this paragraph; it is 41% similar to last year's version.
Demand from customers in China may be adversely affected by China’s evolving laws and regulations, including those relating to taxation, import and export tariffs and restrictions, currency controls, environmental regulations, privacy and information security, indigenous innovation, and intellectual property rights and enforcement of those rights. Enforcement of existing laws or agreements may be inconsistent, and the potential issuance of new laws and regulations creates uncertainty. In addition, changes in the political environment, economic environment, governmental policies, United States-China relations, or China-Taiwan relations could result in revisions to laws or regulations or their interpretation and enforcement, exposure of our intellectual property, increased taxation, restrictions on imports, import duties, or currency revaluations, any of which could have an adverse effect on our business plans and operating results. In particular, the imposition by the United States of new tariffs, including the tariffs announced in 2025, on goods imported from China, or deemed to be of Chinese origin, and other government actions that restrict our ability to sell our products to Chinese customers or to manufacture or source components in China, and countermeasures imposed by China in response, could directly or indirectly adversely impact our manufacturing costs, the availability and cost of materials, including gallium, germanium, antimony, and rare earth metals, and the sales of our products in China and elsewhere. For example, the U.S. government has expanded export restrictions, and might continue expanding export restrictions, including by adding certain Chinese entities to the U.S. Bureau of Industry and Security’s Entity List (“Entity List”) or other entity lists, which has limited, and could in the future limit, our ability to sell to certain of those entities and to third parties that do business with those entities. These restrictions have negatively impacted, and may continue to negatively impact, sales of our products. In the future, we may be prevented from shipping, or be required to obtain a license to ship, our products to certain customers if they are added to the Entity List. In addition, geopolitical changes in China-Taiwan relations could disrupt the operations of several companies in Taiwan that are suppliers to, or third-party partners of, the Company, our customers, and our customers’ other suppliers. Disruption of certain critical operations in Taiwan would adversely affect our ability to manufacture certain products and would likely have substantial negative effects on the entire semiconductor industry. Finally, China’s investments in technology development and manufacturing capability in support of its stated policy of reducing its dependence on foreign semiconductor manufacturers and other technology companies has likely already resulted, and we expect will continue to result, in reduced demand for our products in China and other key markets as well as reduced supply of critical materials for our products.
Source: Item 1A, 10-K 0000004127-25-000085 vs Item 1A, 10-K 0000004127-24-000131
Legal Proceedings 141 words changed in this paragraph; it is 46% similar to last year's version.
The Company monitors the status of legal proceedings and other contingencies on an ongoing basis to assess whether loss contingencies should be recognized and disclosed in its financial statements and footnotes. The Other than as described below, the Company does not believe there are any pending legal proceedings that are at least reasonably possible to result in a material loss. The On June 20, 2025, Denso Corporation filed patent infringement litigation against the Company in the U.S. (United States District Court for the Central District of California) and Japan (Civil Division of the Osaka District Court). Denso alleges that the Company has and is willfully infringing Denso’s U.S. patent (7,758,979) and Japan patent (JP5190841), each relating to piezoelectric thin film. Denso is seeking monetary damages, including enhanced damages, interest, fees and costs, and injunctive relief. While the Company is engaged in various legal actions in unable to determine the normal course ultimate outcome of business and, while there can be no assurances, these suits, the Company believes it has substantial defenses and intends to vigorously oppose the outcome of all pending litigation involving the Company will not have, individually or in the aggregate, a material adverse effect on its business or financial statements. suits.
Source: Item 3, via Note 11 – COMMITMENTS AND CONTINGENCIES, 10-K 0000004127-25-000085 vs Item 3, via Note 11 – COMMITMENTS AND CONTINGENCIES, 10-K 0000004127-24-000131
MD&A 113 words changed in this paragraph; it is 38% similar to last year's version.
Future changes in tax laws could arise related to In December 2021, the BEPS Project of the OECD, including Organization for Economic Co-operation and Development’s (“OECD”) Inclusive Framework on Base Erosion and Profit Shifting (“BEPS”) released Global Anti-Base Erosion (“GloBE”) rules under Pillar One and Pillar Two; the European Commission’s “state aid” investigations; enactment of a global corporate minimum tax; and other developments that could have an adverse effect on the taxation of our business, including reducing the availability of tax credits and payment of higher income taxes. Two. Many countries have implemented laws based on Pillar Two Two, which will be became effective for us beginning in fiscal year 2025. The tax impact associated with Pillar Two was immaterial to the financial statements for fiscal 2025. We continue to evaluate the impact of proposed and enacted legislative changes to our effective tax rate as new guidance becomes available.
Source: Item 7, 10-K 0000004127-25-000085 vs Item 7, 10-K 0000004127-24-000131
Accounting Policies 87 words changed in this paragraph; it is 55% similar to last year's version.
Pricing adjustments and estimates of returns are treated as variable consideration for purposes of determining the transaction price. Sales returns are generally accepted at the Company’s discretion or from distributors with stock rotation rights. Stock rotation allows distributors limited levels of returns and is based on the distributor’s prior purchases. Price protection represents price discounts granted to certain distributors and is based on negotiations on sales to end customers. Variable consideration is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. The Company records net revenue excluding taxes on its sales to trade customers. The Company recognizes shipping fees, if any, received from customers in revenue and includes the related shipping and handling costs in cost of revenue.
Source: Item 8, Note 2 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0000004127-25-000085 vs Item 8, Note 2 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0000004127-24-000131
Every change, by type
Sentences and paragraphs of SWKS's Risk Factors and MD&A, 10-K 2025-11-07 against 10-K 2024-11-15.
Each links to the text at sec.gov.
Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier
(may, could, will, not, significant, material…). A year or date rolling forward is not counted.
The full word list
adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would
AddedRisk Factors
The following is a summary of the principal risks that could adversely affect our business, operations, and financial results. This summary is intended to provide investors with an overview of the risks we face and should not be considered a substitute for the more detailed risk factors discussed immediately following this summary.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•Completion of the proposed transaction with Qorvo may be delayed or not occur at all for a variety of reasons, including that the Merger Agreement is terminated, and the failure to complete the Mergers could adversely affect our business, results of operations, financial condition, and the market price of our common stock.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•Completion of the proposed Mergers is subject to the satisfaction or waiver of closing conditions contained in the Merger Agreement, including certain regulatory approvals which may not be received, may take longer than expected or the receipt of which may impose conditions that are not presently anticipated or that cannot be met, and if these closing conditions are not satisfied or waived, the proposed Mergers will not be completed.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•Efforts to complete the Mergers could disrupt our relationships with third parties and employees, divert management’s attention, or result in negative publicity or legal proceedings, any of which could adversely impact our operating results and ongoing business.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•The Merger Agreement contains provisions that limit our ability to pursue alternative transactions to the Mergers which could discourage a potential third party from making an alternative transaction proposal.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•While the Merger Agreement is in effect, we are subject to restrictions on our business activities.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•As a result of the Mergers, we anticipate that the scope and size of our operations and business will substantially change and will result in certain incremental risks to us, including increased competition. We may not realize the full expected benefits of the Mergers.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•The Mergers will require us to incur substantial additional indebtedness, which could reduce our flexibility to operate our business and negatively affect our financial condition, and increase the risks associated with our level of indebtedness.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•If our senior management transitions are not successful, our business and future growth prospects could be harmed.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
•Our outstanding indebtedness could reduce our flexibility to operate our business.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
Completion of the proposed transaction with Qorvo may be delayed or not occur at all for a variety of reasons, including that the Merger Agreement is terminated, and the failure to complete the Mergers could adversely affect our business, results of operations, financial condition, and the market price of our common stock.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedRisk Factors
On October 27, 2025, we entered into the Agreement and Plan of Merger (“Merger Agreement”) with Qorvo, Inc. (“Qorvo”), Comet Acquisition Corp. (“Merger Sub I”), and Comet Acquisition II, LLC (“Merger Sub II”), pursuant to which Merger Sub I will be merged with and into Qorvo (the “First Merger”), with Qorvo as the surviving entity in the First Merger (the “Surviving Corporation”) with the Surviving Corporation continuing as a wholly owned subsidiary of the Company, and immediately following the First Merger, and as the second step in a single integrated transaction with the First Merger, the Surviving Corporation will be merged with and into Merger Sub II (the “Second Merger,” and together with the First Merger, the “Mergers”), with Merger Sub II as the surviving entity in the Second Merger and a wholly owned subsidiary of the Company. Completion of the Mergers is subject to customary closing conditions, including (1) the adoption of the Merger Agreement by Qorvo’s stockholders, and the approval of the issuance of common stock as merger consideration by the Company’s stockholders as required under Nasdaq listing rules, (2) the expiration or early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the approval of the Mergers under certain other antitrust and foreign investment regimes, (3) the absence of any order, injunction or law prohibiting the Mergers in such jurisdictions, (4) the effectiveness of the registration statement pursuant to which shares of the Company’s common stock to be issued in the Mergers will be registered with the SEC, (5) the accuracy of the other party’s representations and warranties, subject to certain standards set forth in the Merger Agreement, (6) compliance in all material respects by the other party with its obligations under the Merger Agreement, and (7) the absence of a continuing material adverse effect with respect to each party. Therefore, there can be no assurance that the Mergers will be completed in the expected timeframe (early in calendar year 2027), or at all.
Read it in 10-K 2025-11-07 at sec.gov ↗
RemovedRisk Factors
Demand from Chinese customers may be adversely affected by China’s evolving laws and regulations, including those relating to taxation, import and export tariffs and restrictions, currency controls, environmental regulations, privacy and information
Read it in 10-K 2024-11-15 at sec.gov ↗
RemovedRisk Factors
We may not be able to maintain and improve manufacturing yields that contribute positively to our gross margin and profitability.
Read it in 10-K 2024-11-15 at sec.gov ↗
RemovedRisk Factors
The agreements that govern our indebtedness contain various covenants that impose restrictions that may affect our ability to operate our businesses.
Read it in 10-K 2024-11-15 at sec.gov ↗
RemovedRisk Factors
• the ability to secure government incentives and grants, such as funding available under the CHIPS and Science Act of 2022.
Read it in 10-K 2024-11-15 at sec.gov ↗
RewordedRisk Factors
We expect that these and other rapidly changing laws, regulations, policies, interpretations, and expectations, as well as increased enforcement actions by various governmental and regulatory agencies, will continue to increase the cost of our compliance and internal risk management programs and to alter the environment in which we do business, which could have a material adverse effect on our business, results of operations, and financial condition.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
Violations of one or more of these legal regimes’ laws and regulations in the conduct of our business could result in significant fines, penalties, or monetary damages, criminal sanctions against us or our officers, prohibitions on doing business, unfavorable publicity and other reputational damage, restrictions on our ability to process information, and allegations by our counterparties that we have not performed our contractual obligations.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
Furthermore, on August 16, 2022, the U.S. government enacted the Inflation Reduction Act (“IRA”), which imposes The Company is subject to a corporate alternative minimum tax (“CAMT”) of 15% on adjusted financial statement income for certain corporations, income, as well as an excise tax on corporate stock repurchases. repurchases under the Inflation Reduction Act (“IRA”).
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
If such a Such product offering were offerings have been competitive with and may continue to be competitive with our solution as to performance, price, and quality, or which has and could continue to negatively impact our business and financial performance, and if the interoperability of our solution with the partner’s baseband products were to be restricted, our business could be further adversely impacted.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
We do not obtain Where we have achieved design wins on everything that in the past with customers, we compete for, have not continued to and we may not continue to achieve design wins with customers in the future or to may not convert such design wins into actual sales.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
Beginning in fiscal 2023, for U.S. income tax purposes purposes, we were required to capitalize and amortize our research and development expenses and amortize them over five or fifteen years, rather than deduct them in the year incurred, which has increased, and which we expect will continue to increase, our taxes payable, resulting in reduced near term-cash flows. incurred.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
Further, existing immigration laws laws, as well as difficulties and difficulties increased costs in obtaining visas, together with any changes to immigration policies or regulations in the United States, such as the increased cost for H-1B worker visas announced in September 2025, make it more difficult for us to recruit and retain highly skilled foreign national graduates of universities nationals (in the United States or abroad), limiting the pool of available talent.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
The jurisdictions in which we conduct business have and may adopt laws and regulations related to AI, which could cause us to incur greater compliance costs, limit our use of AI tools, or subject us to legal liabilities.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
While the The IRA did not have a material impact to the Company’s financial statements for fiscal 2024, it could have a material impact in future periods depending on various factors, including the amount and frequency of our stock repurchases and the applicability of the CAMT to the Company.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
Such actions could result in the imposition of various remedies such as injunctions or monetary damages, which if awarded could materially and adversely harm our business, subject us to substantial defense costs and expenses, and divert resources and the attention of management from our business.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
Our existing indebtedness or incurrence of any additional indebtedness, including the indebtedness contemplated in connection with the Mergers, could reduce funds available for working capital, capital expenditures, acquisitions, and other general corporate purposes and may create competitive disadvantages relative to other companies with lower debt levels.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedRisk Factors
In addition, certain of our products that we use contain firmware that incorporates or is derived from “open source” software that generally is made publicly available by its developers or other third parties.
Read it in 10-K 2025-11-07 at sec.gov ↗
Quiet changesRisk Factors
Relocation would will be complex and could will require, among other things, the transfer of equipment and process nodes and qualification of new or transferred production lines.
Read it in 10-K 2025-11-07 at sec.gov ↗
Quiet changesRisk Factors
If Additionally, if we are unable to obtain required stockholder approval for future increases in the number of shares available under our long-term incentive plans, we may be limited in granting equity-based incentive awards, which may impair our efforts to attract and retain necessary personnel.
Read it in 10-K 2025-11-07 at sec.gov ↗
Quiet changesRisk Factors
In addition, we often incorporate the intellectual property of our customers, suppliers, or other third parties into our designs, and we have certain obligations with respect to the non-usage and non-disclosure of such third-party intellectual property.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
On October 27, 2025, we entered into the Merger Agreement with Qorvo, a provider of connectivity and power solutions, to combine Qorvo and Skyworks in a cash-and-stock transaction that values the combined company at approximately $22.0 billion as of the market close on October 27, 2025.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
Under the terms of the Merger Agreement, at the effective time of the Mergers, each share of Qorvo common stock issued and outstanding immediately prior thereto (with certain exceptions set forth in the Merger Agreement) will be converted into the right to receive 0.960 (the “Exchange Ratio”) of a share of Skyworks common stock and $32.50 in cash, without interest, subject to applicable withholding taxes. The Exchange Ratio is expected to result in Qorvo equityholders and Skyworks equityholders owning approximately 37% and 63%, respectively, of the combined company on a pro forma basis following the closing. The Merger Agreement also provides for Skyworks’ assumption of certain Qorvo equity awards, subject to certain adjustments thereto in respect of, among other things, performance-based vesting conditions.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
Pursuant to the Merger Agreement, immediately following the closing, the Board of Directors will be comprised of 11 directors, consisting of (i) the Chief Executive Officer of Skyworks, who will be the Chief Executive Officer of Skyworks following the closing, (ii) seven directors designated by Skyworks and (iii) three directors designated by Qorvo who are reasonably acceptable to Skyworks, each of whom will hold office until the next annual meeting of stockholders of Skyworks. Promptly following the closing, the Board of Directors will also designate a Chairman. Robert Bruggeworth, Qorvo’s current President, Chief Executive Officer and director, will be one of Qorvo’s designees upon the closing.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
The Mergers, which are anticipated to close early in calendar year 2027, are subject to the satisfaction or waiver of customary closing conditions, including adoption of the Merger Agreement by Qorvo’s stockholders and the approval by Skyworks’ stockholders of the issuance of Skyworks common stock included in the consideration to be paid to Qorvo stockholders, the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, and other regulatory approvals under certain antitrust and foreign investment regimes, the absence of any order, injunction or law of such jurisdictions prohibiting the Mergers, and the effectiveness of a registration statement on Form S-4 to be filed by us.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
We and Qorvo each have termination rights under the Merger Agreement. Under specified circumstances, including termination by a party to accept a superior proposal or termination by the other party upon a change in such party’s board of directors’ recommendation to its stockholders, each of Qorvo and us will be required to pay the other party a termination fee of $298.7 million, as more fully described in the Merger Agreement. Alternatively, under certain specified circumstances, including termination following an injunction arising in connection with certain antitrust or foreign investment laws, or failure to receive certain required regulatory approvals of specified governmental authorities, we will be required to pay Qorvo a termination fee of $100.0 million, as more fully described in the Merger Agreement.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
In connection with the execution of the Merger Agreement, we entered into a commitment letter (“Bridge Commitment Letter”) on October 27, 2025, with Goldman Sachs Bank USA, which committed to provide, subject to the satisfaction of customary closing conditions, up to $3,050.0 million of senior unsecured bridge term loans for the purpose of financing a portion of the cash portion of the consideration to be paid to Qorvo stockholders, paying related fees and expenses in connection with the Mergers and the other transactions contemplated by the Merger Agreement and, in certain circumstances, to refinance certain of Qorvo’s senior notes. The receipt of financing by us is not a condition to our obligation to consummate the Mergers.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
Concurrently with the execution of the Merger Agreement, we and certain stockholders of Qorvo affiliated with Starboard Value (“SBV”), an affiliate of Peter Feld, a member of the board of directors of Qorvo so designated by SBV (each, a “SBV Stockholder”), entered into a Voting and Support Agreement (the “VSA”), pursuant to which each SBV Stockholder has agreed to vote its shares of Qorvo common stock in favor of the adoption of the Merger Agreement. As of October 24, 2025, the SBV Stockholders collectively held approximately 8% of Qorvo’s issued and outstanding shares. Each SBV Stockholder has also agreed, for a limited period of time not exceeding nine months from the date of the VSA, not to sell or transfer its shares of Qorvo common stock, subject to certain exceptions as specified in the VSA, and has agreed not to solicit any competing acquisition proposal. The VSA will terminate, as to each SBV Stockholder, upon the earliest to occur of (a) the closing, (b) the termination of the Merger Agreement, (c) the date of any Qorvo Triggering Event or Skyworks Triggering Event (each, as defined in the Merger Agreement) and (d) the written consent of Skyworks, Qorvo and the applicable SBV Stockholder.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
For more on risks related to the Mergers, see Part I, Item 1A, Risk Factors, “Risks Associated with the Proposed Transaction with Qorvo” of this Annual Report on Form 10-K.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
•On February 4, 2025, the Board of Directors appointed Philip Brace as the President and Chief Executive Officer of the Company and as a director, effective February 17, 2025.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
•On May 7, 2025, the Board of Directors appointed Todd Lepinski as Senior Vice President, Sales and Marketing, effective as of June 2, 2025.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
•On August 23, 2025, the Board of Directors appointed Philip Carter as Senior Vice President and Chief Financial Officer of the Company, effective as of September 8, 2025.
Read it in 10-K 2025-11-07 at sec.gov ↗
AddedMD&A
In July 2025, the U.S. government enacted the One Big Beautiful Bill Act (“OBBBA”). The OBBBA did not have a material impact to the financials for fiscal 2025. We continue to evaluate the impact of the OBBBA on our business for future periods.
Read it in 10-K 2025-11-07 at sec.gov ↗
RemovedMD&A
Fiscal Years Ended September 27, 2024, September 29, 2023, and September 30, 2022
Read it in 10-K 2024-11-15 at sec.gov ↗
RemovedMD&A
dividend payments of $439.1 million, repayments of debt of $300.0 million, capital expenditures of $157.0 million, and share repurchases of $77.3 million.
Read it in 10-K 2024-11-15 at sec.gov ↗
RemovedMD&A
transaction price when sales are recorded. Changes in actual demand or market conditions could adversely or beneficially impact our reserve calculations.
Read it in 10-K 2024-11-15 at sec.gov ↗
RewordedMD&A
We recorded a provision for income taxes of $49.6 million (which consisted of a benefit of $35.5 million and a provision of $0.1 million related to United States federal and state income taxes, respectively, and a provision of $85.0 million related to foreign income taxes) and $40.4 million (which consisted of benefits of $41.5 million and $0.3 million related to United States federal and state income taxes, respectively, and a provision of $82.2 million related to foreign income taxes) and $96.0 million (which consisted of $62.0 million and $34.0 million related to United States and foreign income taxes, respectively) in fiscal 2024 2025 and fiscal 2023, 2024, respectively.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The $660.2 $455.1 million decrease increase in cash used in financing activities for fiscal 2024, 2025, as compared to fiscal 2023, 2024, was primarily related to an increase of $752.9 million in share repurchases, partially offset by a decrease of $600.0 $300.0 million for the repayment of debt and a decrease of $98.0 million in stock repurchase activity, partially offset by an increase of $33.9 million in dividend payments. debt.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The increase in research and development expenses in fiscal 2024, 2025, as compared to fiscal 2023, 2024, was primarily related to increases in certain headcount-related expenses expenses, including share-based compensation and costs for engineering prototypes as a result of our increased investment in developing new technologies and products, partially offset by a decrease in share-based compensation expense and a decrease in depreciation expense as a result of extending the useful lives of certain machinery and equipment. products.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The decrease increase in selling, general, and administrative expenses in fiscal 2024, 2025, as compared to fiscal 2023, 2024, was primarily related to a gain on the sale of property, plant, increases in headcount-related expenses, including share-based compensation and equipment, a decrease increases in professional services costs, and a decrease in share-based compensation expense. costs.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
Research and development 19.2 15.1 12.7 11.3 Selling, general, and administrative 9.1 7.2 6.6 6.0 Amortization of intangibles — — 0.7 1.8 Impairment, restructuring, Restructuring, impairment, and other charges 0.6 3.6 0.6 0.6 Total operating expenses 28.9 25.9 20.6 19.7 Operating income 12.2 15.3 23.6 27.8 Interest expense (0.7) (0.7) (1.3) (0.9) Other income (expense), income, net 1.3 0.7 0.4 — Income before income taxes 12.9 15.2 22.6 26.9 Provision for income taxes 1.2 1.0 2.0 3.7 Net income 11.7 % 14.3 % 20.6 % 23.2% 20.6%
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The increase decrease in cash, cash equivalents, and marketable securities during fiscal 2024, 2025 was primarily due to share repurchases of $830.2 million, dividend payments of $432.6 million, and capital expenditures of $195.0 million, partially offset by cash generated from operations of $1,824.7 million, partially offset by $1,300.8 million.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The decrease in gross profit in fiscal 2024, 2025, as compared to fiscal 2023, 2024, was primarily the result of an unfavorable product mix, lower unit volumes, and lower average selling prices. prices, and an increase in costs associated with facility consolidation and closure, partially offset by higher unit volumes.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The $31.7 $523.9 million decrease in cash provided by operating activities for fiscal 2024, 2025, as compared to fiscal 2023, 2024, was primarily related to lower net income, partially offset by favorable changes a decrease in working capital of $402.9 $370.7 million, due primarily to a decrease in inventory and accounts receivable. receivable, and lower net income.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
Fiscal Years Ended (dollars in millions) October 3, 2025 Change September 27, 2024 Change September 29, 2023 Change September 30, 2022 Impairment, restructuring, Restructuring, impairment, and other charges $ 24.2 (83.9)% $ 150.0 430.0% $ 28.3 (7.8)% $ 30.7 % of net revenue 0.6 % 3.6 % 0.6 % 0.6 %
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
The decrease in net revenue in fiscal 2024, 2025, as compared to fiscal 2023, 2024, was driven primarily by a decrease in market share at a significant customer, partially offset by an increase in demand for our mobile, analog, mobile and mixed-signal Wi-Fi products.
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
Fiscal Years Ended (in millions) October 3, 2025 September 27, 2024 September 29, 2023 September 30, 2022 Cash and cash equivalents at beginning of period $ 1,368.6 $ 718.8 $ 566.0 $ 882.9 Net cash provided by operating activities 1,300.8 1,824.7 1,856.4 1,424.6 Net cash used in investing activities (234.0) (355.9) (224.4) (378.9) Net cash used in financing activities (1,274.1) (819.0) (1,479.2) (1,362.6) Cash and cash equivalents at end of period $ 1,161.3 $ 1,368.6 $ 718.8 $ 566.0
Read it in 10-K 2025-11-07 at sec.gov ↗
RewordedMD&A
Fiscal Years Ended (dollars in millions) October 3, 2025 Change September 27, 2024 Change September 29, 2023 Change September 30, 2022 Research and development $ 785.5 24.3% $ 631.7 4.1% $ 606.8 (1.8)% $ 617.9 % of net revenue 19.2 % 15.1 % 12.7 % 11.3 %
Read it in 10-K 2025-11-07 at sec.gov ↗